Journal Specifications
Indexed in the following public directories
Scopus
- PublisherChinese Medical Journals Publishing House Co.Ltd
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
FAQs
Who is the publisher of Journal of Leukemia and Lymphoma? 
The publisher of Journal of Leukemia and Lymphoma is Chinese Medical Journals Publishing House Co.Ltd.
How can I view the journal metrics of Journal of Leukemia and Lymphoma on editage? 
For the Journal of Leukemia and Lymphoma metrics, please refer to the section above on the page.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Diffuse large B-cell lymphoma, Acute leukemia, Myeloid leukemia, Fusion gene, Bone marrow, Bortezomib, Overall survival, Hematopoietic stem cell transplantation, Chimeric antigen receptor, Mixed phenotype acute leukemia, Rituximab, Polycythemia vera, Consolidation therapy, Lenalidomide, Progression-free survival, Cell lymphoma, Minimal residual disease, Imatinib, Retinoic acid, Macroglobulinemia.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.